[{"indications": "Indications\u00a0hereditary tyrosinaemia type I (specialist\r\nuse only)", "name": "NITISINONE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.8 Metabolic disorders", "9.8.1 Drugs used in metabolic disorders", "Tyrosinaemia type I", "NITISINONE"], "cautions": "Cautions\u00a0slit-lamp examination of eyes recommended\r\nbefore treatment; monitor liver function\r\nregularly; monitor platelet and white blood\r\ncell count every 6 months", "side-effects": "Side-effects\u00a0thrombocytopenia, leucopenia, granulocytopenia;\r\nconjunctivitis, photophobia, corneal opacity, keratitis, eye pain; less commonly leucocytosis, blepharitis, pruritus, exfoliative\r\ndermatitis, and erythematous rash", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/130125.htm", "doses": ["adult and child initially 500\u00a0micrograms/kg twice daily, adjusted\r\naccording to response; max. 2\u00a0mg/kg daily", "Capsules can be opened and the contents suspended\r\nin a small amount of water or formula diet and taken immediately"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless potential benefit\r\noutweighs risk\u2014toxicity in animal studies"}]